Expression Level of Caspase Genes in Colorectal Cancer

• Published in: Asian Pacific journal of cancer prevention : APJCP Vol. 19; no. 5; pp. 1277 - 1280
• Main Authors: Asadi, Milad, Shanehbandi, Dariush, Asvadi Kermani, Touraj, Sanaat, Zohreh, Zafari, Venus, Hashemzadeh, Shahriyar
• Format: Journal Article
• Language: English
• Published: Thailand West Asia Organization for Cancer Prevention 26.05.2018
• Subjects: mRNA level; gene expression; Colorectal cancer; caspase
• ISSN: 1513-7368; 2476-762X
• DOI: 10.22034/APJCP.2018.19.5.1277

Background: Caspases proteins are protease enzymes involved in the initiation and execution of apoptosis process. Regulation of apoptosis process plays an important role in the normal biological events and development. In addition to developmental abnormalities, dysregulated apoptosis system may lead to tumorigenesis, autoimmunity, and other serious health problems. Aberrant regulation of apoptosis may also be the paramount cause of chemoresistance during cancer therapy. It is aimed through this study to evaluate the transcript levels of Caspase 3, 8, and 9 in tumoral tissues from patients with colorectal cancer (CRC) and compare it with normal marginal tissues. Methods: Fifty tumor tissues and their matched marginal tissues, as control group, were obtained from CRC patients. Total mRNA of all tissue samples was extracted and cDNA was synthesized. Using SYBR Green PCR master mix and Real-time gene expression technique, the transcript level of target genes was quantified. Results: Experiments indicated that mRNA expressions of caspase 9 and 3 were downregulated in tumoral tissues from CRC patients in comparison to marginal tissues. In contrast, tumoral tissues expressed mRNA of caspase 8 higher than normal marginal tissues. Modified transcript levels of caspase 3, 8, and 9 were correlated with the clinical manifestations of the patients. Conclusions: Alteration in the mRNA level of caspase genes may be involved in the development of CRC.